INS and type 1 diabetes mellitus: The primary contributions of this study include: firstly, the development of an artificial intelligence-driven T1D simulator featuring both open-loop and closed-loop insulin therapies; secondly, the causal generation of BG values using GANs; and thirdly, the generation of realistic T1D patient profiles, conditioned on insulin and carbohydrate values.